Background/Aims: Schizophrenia is a severe psychiatric disorder, and complement 3 (C3) is closely related to schizophrenia. We investigated the association between C3 polymorphisms and schizophrenia in a Northeast Han Chinese population. Methods: A total of 2240 Chinese people, consisting of 1086 patients with schizophrenia and 1154 healthy controls, were recruited for this study. Ten single nucleotide polymorphisms (
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Introduction
Schizophrenia (SCZ) is a severe mental disorder that affects approximately 0.5-1% of the population worldwide and has a profound impact on society and the economy [1, 2] . SCZ is highly prevalent among young adults [3] , and its incidence rate is slightly higher in males than in females (1.4:1) [4] . Compared with the general population, patients with SCZ
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have a shortened life span [5] and experience a wide variety of symptoms, including serious depression, substance abuse, obsessive-compulsive behavior, cognitive learning deficits, and memory problems [6, 7] .
The etiology and pathogenesis of SCZ are still not understood clearly. Numerous studies have shown that SCZ is caused by a combination of multiple risk factors, which can be broadly classified into genetic factors (intrinsic factors) and environmental factors (external factors). Therefore, SCZ is the result of an interaction between genes and the environment [8, 9] . The importance of genetic components as well as developmental and environmental influences in SCZ has been demonstrated by family, twin, and adoption studies [10] [11] [12] .
Recently, a large-scale genome-wide association study demonstrated that multiple genetic risk factors contribute to the occurrence of SCZ [13] . While previous studies have emphasized the polygenic nature of SCZ, it is a challenge to provide a comprehensive explanation linking genetic associations with the underlying pathophysiology.
SCZ has high heritability (approximately 60-80%) [14] . Over the past few decades, variants in several candidate genes, including DRD2, ZNF804A, CHGB, NRGN, SHANK3, BACE1, FGA, and complement 3 (C3), were found to be associated with SCZ [15] [16] [17] [18] [19] [20] . Particularly, the concentration of C3 in the blood of patients with SCZ has been extensively studied, and the role of complement in SCZ is beginning to be more widely explored. Several studies have shown that the level of C3 is higher in the blood of SCZ patients than in healthy subjects, indicating that the C3 fast (F) allotype may be a potential biomarker for the diagnosis of SCZ [21] .
Although C3 may play a potential role in SCZ, the pathophysiology of SCZ remains unknown [22] . Due to the importance of C3 in multiple immunoregulatory processes, the investigation of C3 polymorphisms remains of interest in SCZ research. However, a handful of genetic studies have been performed to study the association between single nucleotide polymorphisms (SNPs) in C3 and SCZ, but no significant association has been discovered [16] . In this study, we selected 10 SNPs of C3 (rs11569562, rs344555, rs2241393, rs2241392, rs11569514, rs445750, rs451760, rs11672613, rs2230205, and rs2250656) to examine the association between C3 variation and SCZ.
Materials and Methods
Participants
This study was approved by the Ethics Committee of the School of Public Health, Jilin University. All participants provided written informed consent before enrolling in the study.
A total of 1086 patients with SCZ were enrolled from the Sixth Hospital of Changchun City and the Encephalopathy Hospital of Jilin Province, from 2006 to 2012. All participants belonged to the Han population in China. Each patient was diagnosed by two or more physicians based on the International Classification of Diseases 10 criteria for SCZ, and in the meantime, referred to the Chinese Psychiatric Classification and Diagnostic Criteria Program, Third Edition.
Control subjects were 1154 healthy Han Chinese volunteers enrolled from the First Hospital of Jilin University in Changchun City, Jilin Province, China. Before sampling, all control subjects were physically healthy and had no family history of mental illness. Those with a medical illness or drug and alcohol abuse/ dependence were excluded.
SNP selection and genotyping
Based on previous studies, we selected 10 tag SNPs (rs11569562, rs344555, rs2241393, rs2241392, rs11569514, rs445750, rs451760, rs11672613, rs2230205, and rs2250656) in C3 using the Haploview program (http://hapmap.ncbi.nlm.nih.gov/) [23] . The threshold for the minor allele frequency of these 10 tag SNPs was set at greater than 0.1 in CHB with r 2 > 0.8. We collected a 5-mL blood sample from each subject and stored the specimen at -20°C in an anticoagulant Plexiglas tube. For genotyping these 10 SNPs, we utilized a commercial DNA extraction kit (ClotBlood DNA kit, Catalog number: CW0565, Beijing, China) and extracted genomic DNA from peripheral blood lymphocytes, according to the manufacturer's instructions. Assay Design software 3.1 (Sequenom, Inc., San Diego, CA) was used to design PCR primers for each SNP (Table 1) . Genomic DNA amplification was conducted using specific forward and reverse primer pairs. HotStarTaq Master Mix Kit (Qiagen, Hilden, Germany) was used for PCR. PCR amplification conditions were set for an initial cycle at 94°C for 15 min, 45 cycles at 94°C for 20 s, 56°C for 30 s, and 72°C for 60 s, and finally 72°C for 3 min. PCR products were subjected to the shrimp alkaline phosphatase reaction and single-base extension. After desalting, the PCR products were analyzed using the MassARRAY system (Sequenom, Inc.) for SNP genotyping.
Statistical analysis
Statistical software SPSS 24.0 (SPSS Inc., Chicago, IL) was used to analyze the data. The c 2 test or Student's t-test was used to compare sex and age differences, respectively, between the SCZ and control groups. The Hardy-Weinberg disequilibrium test was applied to evaluate each SNP in both groups. Odds ratios (ORs) and 95% confidence intervals (CIs) for SNPs in C3 associated with SCZ were tested with logistic regression models adjusted for age and gender. Quanto 1.2.4 software was used to calculate the statistical power of the sample. The Akaike information criterion was used to select the best genetic model for each SNP. The SNPStats program (http://bioinfo.iconcologia.net/SNPStats) [24] was applied to carry out haplotype analysis: the most frequent haplotype was regarded as the reference group. A P-value of 0.05 or less was used to determine statistical significance, and all statistical tests were twosided.
Results
The average age of the SCZ patients and controls was 34.24 ± 12.26 years and 36.47 ± 10.93 years, respectively; the cases were significantly younger than the controls (P < 0.001). There was a statistically significant sex difference between the cases and controls (c 2 = 8.733, P = 0.003). In the Hardy-Weinberg equilibrium (HWE) test, we found that the genotype distributions of the 10 tag SNPs in both the SCZ group and control group were in accordance with the HWE. The genotype distributions of rs11569514 and rs11672613 revealed a deviation from the HWE in the patient group. We randomly selected 10% of samples from the case group to check the genotypes of rs11569514 and rs11672613, and no genotyping errors were found.
We found no significant difference in the allele frequencies of the 10 tag SNPs of C3 between the SCZ patients and healthy controls in multivariable logistic regression models ( Table 2 ). As shown in Table 3 , the genotype frequencies of these 10 tag SNPs in C3 indicated that rs11569514 was significantly different between the cases and controls (P = 0.035), but there was no significant difference in the genotype distribution of the other 9 SNPs between the SCZ and control groups. The inheritance model for rs11569562, rs344555, rs2241393, and rs2250656 was dominant, the inheritance model for rs2241392, rs11672613, and rs2230205 was overdominant, the inheritance model for rs445750 and rs451760 was recessive, and the inheritance model for rs11569514 was codominant ( Table  4) . In the dominant model (AA vs. GG+GA genotypes), we found a significantly protective effect for variant rs344555 on SCZ (OR: 0.72, 95% CI: 0.53-0.99, P = 0.040). In the codominant model, we also found a significant association between rs11569514 and SCZ in the TT vs. AA genotype comparison (OR: 4.39, 95% CI: 2.06-9.37, P < 0.0001).
Polygenic diseases may be associated with a specific combination of alleles, rather than a single allele. To assess the combined effects of the SNPs in C3 on SCZ, we performed haplotype analyses (Table 5) . Haplotypes AG (rs344555-rs2241393), CGGGT (rs11569562-rs344555-rs2241393-rs2241392-rs11569514), and ACGTG (rs11569514-rs445750-rs451760-rs11672613-rs2230205) were associated with an increased risk for SCZ (OR: 1.29, 95% CI: 1.00-1.66, P = 0.049; OR: 1.85, 95% CI: 1.18-2.91, P = 0.0073; OR: 1.37, 95% CI: 1.01-1.85, P = 0.044, respectively). Haplotypes TG (rs11569562-rs344555) and TGG (rs11569562-rs344555-rs2241393) were associated with SCZ (OR: 0.81, 95% CI: 0.69-0.95, P = 0.012; OR: 0.76, 95% CI: 0.60-0.96, P = 0.019, respectively). No other haplotype showed a significant association with SCZ.
We also calculated the power of these 10 tag SNPs with an OR ranging from 1.4 to 2.0 (α = 0.05, two-tailed test) to detect genetic variance of complex traits using SNP data in unrelated samples. We detected a power of 0. 
Discussion
In the study, we found no significant difference in the allele frequencies of the 10 examined SNPs in C3 between the cases and controls. However, we did observe a significant difference in the genotype distribution of rs11569514 between SCZ patients and normal controls. Haplotype analyses suggested that there was a combined effect of SNPs in C3 on the risk of developing SCZ.
Over the past decade, variants in several candidate genes have been shown to be associated with SCZ, a polygenic disease. BACE1 variants had a significant association with SCZ in an Iranian population [20] . Weiss's group [17] indicated that several variants of SHANK3 had associations with SCZ. Gender-specific associations between variants of CHGB and SCZ have been revealed in a Korean population by Shin et al. [15] . Conversely, a casecontrol study indicated that there was no significant association between SNPs of FGA and SCZ [19] .
The complement system plays a crucial role in innate immunity and also regulates adaptive immune processes [25] . The C3 component of the complement system also plays a central role in the cascade of all three complement activation pathways (alternative, classical, and lectin) [26, 27] . While a lack of C3 can contribute to recurrent immune problems, excessive activation of complement proteins is associated with various diseases including Alzheimer's syndrome, Crohn's disease, SCZ, and others [28] . Animal models have demonstrated that the immune system is associated with the development of SCZ [29] . Complex variation of another member of the complement system, C4, has also been shown to be associated with SCZ [30] .
The distribution of three types of C3 (F, FS, and S) is different between SCZ patients and healthy controls. The frequency of the C3F gene allele was significantly higher in SCZ patients than in controls [31] . Hakobyan et al. showed that C3 hemolytic activity was 2.01-fold higher in SCZ patients than in healthy controls [32] . dos Santos Sória et al. reported that C3 was significant higher in SCZ patients than in control subjects [33] . Nsaiba et al. also demonstrated that C3 was increased in SCZ patients [34] .
Although these studies concluded that C3 concentration was significant higher in SCZ patients than in controls [32] [33] [34] , normal serum levels of C3 in patients with chronic SCZ and lower serum levels of C3 in male Chinese SCZ patients have been reported [35] [36] [37] [38] . Therefore, it is necessary to study the relationship between C3 variants and SCZ.
A preliminary investigation on the association of 5 SNPs (rs2277984, rs7951, rs11672613, rs2230205, and rs2230199) in C3 with SCZ found no significant association between these SNPs and SCZ [16] . In our study, we increased the number of subjects and studied the association of 10 tag SNPs (rs11569562, rs344555, rs2241393, rs2241392, rs11569514, rs445750, rs451760, rs11672613, rs2230205, and rs2250656) in C3 with SCZ. We observed a significant difference in the genotype distribution of rs11569514 between the SCZ patients and healthy controls. We also found associations between haplotypes of C3 variants and SCZ.
This study had several limitations. First, the inadequate power of several SNPs may have had an effect on the null association of C3 and SCZ. The range of our sample detection rates was 90.9-99.2%, so some subjects were not included in the genotype analysis of the 10 SNPs, and this might have introduced a selection bias into our study. We studied the association between C3 and SCZ at the genetic level, and further study of the association between C3 and SCZ at the transcriptional and protein levels is necessary.
In summary, this study tested the association between 10 tag SNPs in C3 and SCZ. To our knowledge, this is the first study to confirm a significant association between C3 variants with SCZ in a northern Chinese Han population. Despite the study limitations, our results may provide useful evidence on the genetic etiology of SCZ.
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